A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Accounts Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Accounts Receivables
$613.7m
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
18%
Johnson & Johnson
NYSE:JNJ
Accounts Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Receivables
$10.1B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
19%
Pfizer Inc
NYSE:PFE
Accounts Receivables
$11.4B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Accounts Receivables
$11.6B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Accounts Receivables
$11B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
11%

See Also

What is Amneal Intermediate Inc's Accounts Receivables?
Accounts Receivables
613.7m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Accounts Receivables amounts to 613.7m USD.

What is Amneal Intermediate Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
18%

Over the last year, the Accounts Receivables growth was -17%. The average annual Accounts Receivables growth rates for Amneal Intermediate Inc have been -1% over the past three years , 5% over the past five years , and 18% over the past ten years .

Back to Top